NFE2L2 and neoplasm: The tumor mutation burden values in the Nrf2-High expression group was significantly higher than that in the Nrf2-Low group (11.21 ± 0.459 mut/Mb vs. 8.82 ± 0.670 mut/Mb (P < 0.05)) (Fig. 1a).